Diabetes-related acute care utilization following initiation of automated insulin delivery (AID): A comparison of a disposable tubeless AID system and durable tubed systems.

Joshua Weinstein¹, Duy Do¹, Kellee Miller¹, Dan Carlow¹

¹Insulet Corporation, Acton, MA.

Abstract

BACKGROUND: Automated insulin delivery (AID) has quickly become a core pillar of standard of care for type 1 and insulin-requiring type 2 diabetes. Little evidence exists regarding rates of acute diabetes-related events requiring medical care and how they may differ across different AID systems. OBJECTIVE: To assess whether new users of a disposable tubeless AID system experience different diabet…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.